5-HT7 receptor mRNA expression in human trigeminal ganglia

Neuroscience Letters

Volumn 302, Issue 1, 2001, Pages 9-12

  Terrón, José A ^a   Bouchelet, Isabelle ^a   Hamel, Edith ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

5 HT7 receptor mRNA; Human Trigeminal ganglia; Migraine; Neurogenic inflammation; Pain

Indexed keywords

COMPLEMENTARY DNA; PRIMER DNA; SEROTONIN 7 RECEPTOR; MESSENGER RNA; SEROTONIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MIGRAINE; MOLECULAR CLONING; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRIGEMINUS GANGLION; METABOLISM; OCCIPITAL LOBE; PARIETAL LOBE;

FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; OCCIPITAL LOBE; PARIETAL LOBE; RECEPTORS, SEROTONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGEMINAL GANGLION;

EID: 0035853272     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01617-2     Document Type: Article

References (31)

1. 7) positively linked to adenylate cyclase
2. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels
3. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura matter
4. Serotonergic modulation of hyperpolarization-activated current in isolated rat dorsal root ganglion neurons
5. A reagent for the single-step isolation of RNA, DNA and proteins from cell and tissues samples
6. 1A receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein
7. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: Molecular and pharmacologic characterization
8. Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration
9. 7 receptor: Orphan found
10. 1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice
11. 5-HT3 receptor antagonists and migraine therapy
12. Presynaptic serotonin receptors in the central nervous system
13. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
14. 5-Hydroxytryptamine and the pathophysiology of migraine
15. 1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs
16. 1B immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs
17. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine
18. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: Potential implications for prophylactic and acute therapy
19. Dual effect of the serotonin agonist, sumatriptan, on peripheral neurogenic inflammation
20. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: A polymerase chain reaction study
21. 5-Hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: A polymerase chain reaction study
22. Dα serotonin receptor gene expression in trigeminal ganglia: Implications for antimigraine drug development
23. 7 activating cAMP formation
24. Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headaches
25. 7 serotonin receptor subtype
26. Mediation of serotonin hyperalgesia by the cAMP second messenger system
27. 7 receptor: A target for novel therapeutic avenues?
28. 7 receptor in cerebrovascular vasodilation: Potential impact in migraine
29. 7 receptor mediating smooth muscle relaxation in canine cerebral arteries
30. Treatment of migraine attacks with sumatriptan
31. 7 receptors in guinea-pig brain